From: Correlation between overall survival and quality of life in colon cancer patients with chemotherapy
Overall survival | ||
---|---|---|
HR (95.0% CI) | P-value | |
ICF vs. ICR | 2.19 (1.00–4.82) | 0.052 |
SEX(female vs. male) | 1.33(0.74–2.38) | 0.347 |
age (≦70 vs.>70 years) | 0.98(0.50–1.92) | 0.954 |
site(right vs. left) | 0.42(0.17–1.02) | 0.054 |
histology | ||
 well differentiated vs. poorly or undifferentiated | 0.47(0.15–1.51) | 0.205 |
 moderately differentiated. vs. poorly or undifferentiated | 0.45(0.16–1.31) | 0.142 |
 RAS (wild vs. mutant) | 0.55(0.29–1.03) | 0.062 |
ECOG PS | ||
 0 vs. 2 | 1.85(0.68–5.01) | 0.225 |
 1 vs. 2 | 1.92(0.79–4.67) | 0.149 |
 liver metastasis (-) vs. (+) | 0.66(0.32–1.40) | 0.280 |
 lung metastasis (-) vs. (+) | 0.84(0.42–1.67) | 0.610 |
 peritoneal metastasis (-) vs. (+) | 0.47(0.17–1.32) | 0.152 |
 Locally advanced tumour (-) vs. (+) | 0.27(0.11–0.65) | <0.005* |